Mayo Clinic CEO John Noseworthy says his company's investments in genome research, stem cells and regenerative medicine, and new, cheaper ways to deliver quality care, will transform the future of patient care.

Most Popular

  • untitled
In this ongoing interview series, FORTUNE senior editor-at-large Geoff Colvin examines the biggest challenges in business through conversations with top executives at the heart of those issues.